BackenGene Holdings Overview

enGene Holdings EBIT

enGene Holdings's EBIT is $-71M, below the sector sector average of $-6.4M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$31.97M
217.86% YoY

As of Apr 30, 2026

Annual EBIT (TTM)

-$70.83M
1384.84% YoY

Trailing 12 months ending Apr 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

enGene Holdings (ENGN) FAQ

As of the most recent data (April 2026), ENGN shows a EBIT of $-71M. That compares with $5.5M in the prior-year period — down 1384.8% year over year. That is below the sector sector average of $-6.4M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENGN's EBIT is now $-71M (was $5.5M) — a 1384.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether enGene Holdings is outperforming or lagging.

The its sector sector average EBIT is about $-6.4M. enGene Holdings is at $-71M, which is lower that average. That is roughly 1006.4% below the sector mean. Use the comparison chart on this page to see how ENGN stacks up against individual peers as well.

Tracking ENGN's ebit over time shows whether enGene Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $-71M That compares with $5.5M in the prior-year period — down 1384.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has enGene Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-71M) with ownership activity and broader fundamentals.